FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma
DL Schwartz, E Ford, J Rajendran, B Yueh… - International Journal of …, 2005 - Elsevier
PURPOSE: Image localization of head-and-neck squamous cell carcinoma lags behind
current techniques to deliver a precise radiation dose with intensity-modulated radiotherapy …
current techniques to deliver a precise radiation dose with intensity-modulated radiotherapy …
Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: a multi-institution cohort study by the MIRI collaborative
Purpose The therapeutic ratio of reirradiation for recurrent or second primary (RSP)
squamous carcinoma of the head and neck may be improved in the intensity modulated …
squamous carcinoma of the head and neck may be improved in the intensity modulated …
[HTML][HTML] Cisplatin eligibility issues and alternative regimens in locoregionally advanced head and neck cancer: recommendations for clinical practice
P Szturz, V Cristina, RG Herrera Gómez… - Frontiers in …, 2019 - frontiersin.org
Well-designed randomized trials provide the highest level of scientific evidence to guide
clinical decision making. In chemoradiotherapy of locally advanced squamous cell …
clinical decision making. In chemoradiotherapy of locally advanced squamous cell …
[HTML][HTML] Treatment de-intensification strategies for head and neck cancer
JR Kelly, ZA Husain, B Burtness - European Journal of Cancer, 2016 - Elsevier
Increasingly, squamous cell carcinoma of the oropharynx (OPSCC) is attributable to
transformation resulting from high-risk human papillomavirus (HPV) infection. Such cancers …
transformation resulting from high-risk human papillomavirus (HPV) infection. Such cancers …
Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy
A Argiris, BE Brockstein, DJ Haraf, KM Stenson… - Clinical cancer …, 2004 - AACR
Purpose: The purpose of this retrospective analysis was to evaluate the emergence of
second primary malignancies and the contribution of different causes of death to the …
second primary malignancies and the contribution of different causes of death to the …
[HTML][HTML] Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
I Summerer, K Unger, H Braselmann… - British journal of …, 2015 - nature.com
Background: The prediction of therapy response in head and neck squamous cell cancer
(HNSCC) requires biomarkers, which are also a prerequisite for personalised therapy …
(HNSCC) requires biomarkers, which are also a prerequisite for personalised therapy …
PET monitoring of therapy response in head and neck squamous cell carcinoma
H Schöder, M Fury, N Lee, D Kraus - Journal of Nuclear Medicine, 2009 - Soc Nuclear Med
In the Western world, more than 90% of head and neck cancers are head and neck
squamous cell carcinomas (HNSCCs). The most appropriate treatment approach for …
squamous cell carcinomas (HNSCCs). The most appropriate treatment approach for …
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience
J Setton, N Caria, J Romanyshyn, L Koutcher… - International Journal of …, 2012 - Elsevier
PURPOSE: To update the Memorial Sloan-Kettering Cancer Center's experience with
intensity-modulated radiotherapy (IMRT) in the treatment of oropharyngeal cancer (OPC) …
intensity-modulated radiotherapy (IMRT) in the treatment of oropharyngeal cancer (OPC) …
[HTML][HTML] Mitochondrial superoxide dismutase in cisplatin-induced kidney injury
Cisplatin is a chemotherapy agent commonly used to treat a wide variety of cancers. Despite
the potential for both severe acute and chronic side effects, it remains a preferred …
the potential for both severe acute and chronic side effects, it remains a preferred …
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer
PURPOSE: To evaluate the prognostic value of metabolic tumor volume measured on 18F-
fluorodeoxyglucose positron emission tomography (FDG-PET) imaging and other clinical …
fluorodeoxyglucose positron emission tomography (FDG-PET) imaging and other clinical …